Table 1.
Patient no. | mRNA* (normal tissues) | mRNA* (tumor tissues) | Fold increase (tumor/normal) |
---|---|---|---|
1 | 2.5E-05 | 1.4E-03 | 53.6 |
2 | 2.2E-04 | 8.2E-03 | 38.2 |
3 | 7.8E-05 | 1.6E-03 | 20.4 |
4 | 5.5E-05 | 7.4E-04 | 13.5 |
5 | 2.1E-04 | 1.6E-03 | 7.5 |
6 | 1.0E-04 | 6.6E-04 | 6.5 |
7 | 2.4E-04 | 1.1E-03 | 4.5 |
8 | 1.1E-04 | 4.4E-04 | 3.9 |
9 | 1.9E-04 | 5.8E-04 | 3.1 |
10 | 7.5E-04 | 2.2E-03 | 2.9 |
11 | 4.9E-04 | 1.4E-03 | 2.9 |
12 | 2.1E-04 | 5.4E-04 | 2.6 |
13 | 3.5E-04 | 7.5E-04 | 2.1 |
14 | 3.6E-04 | 6.4E-04 | 1.8 |
15 | 3.8E-04 | 6.2E-04 | 1.6 |
16 | 8.2E-05 | 1.2E-04 | 1.5 |
17 | 2.7E-04 | 2.2E-04 | 0.8 |
*Relative ZIP4 mRNA levels was normalized to that of β-actin and presented as 2̂(Ct[β-actin] − Ct[ZIP4]).